Condition: Allogeneic Stem Cell Transplant Recipient · Sponsor: Hackensack Meridian Health
The Flu-TBI 800 trial is a prospective, single-arm, multicenter, interventional phase 2 study to evaluate whether fludarabine plus intermediate-dose total body irradiation (TBI 800 cGy) with post-transplant cyclophosphamide (PTCy) (experimental regimen) improves the 1-year survival of allogeneic stem cell transplant recipients.
This description comes directly from the study's public registry record.
Oncology Clinical Research Referral Office · 551-996-1777 · OncologyResearchReferral@hmhn.org
Always discuss trial participation with your own doctor first.
| Lombardi Comprehensive Cancer Center at Georgetown University Medical Center | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| John Theurer Cancer Center at Jersey Shore University Medical Center | Neptune City, New Jersey, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07214688